Our Team
John Seaberg, Co-Founder and Chairman
Alexander S. Yevzlin, MD, CEO, CMO, Co-Founder and Director
Alexander S. Yevzlin, MD, CEO, CMO, Co-Founder and Director
Currently, Mr. Seaberg is Chairman of Preceptis Medical, a device company in the ENT space. In addition, he is the Executive VP at Cedar Point Capital, a boutique broker-dealer focused on conducting capital raises for private companies, with a historical emphasis on the healthcare space. Mr. Seaberg is Chairman of Admedus, a publicly li
Currently, Mr. Seaberg is Chairman of Preceptis Medical, a device company in the ENT space. In addition, he is the Executive VP at Cedar Point Capital, a boutique broker-dealer focused on conducting capital raises for private companies, with a historical emphasis on the healthcare space. Mr. Seaberg is Chairman of Admedus, a publicly listed (ASX-AHZ) Australian diversified global healthcare company. Mr. Seaberg also is Chairman of Medicom Health Interactive, a health care IT company that provides health assessments for a variety of medical conditions. Mr Seaberg is the Co-founder and Chairman of Phraxis, Inc. Previously, Mr. Seaberg served as the CEO and was the former Vice President of sales of NeoChord Inc. At Guidant Corp he worked in Cardiac Rhythm Management and was Vice President of Sales, Cardiac Surgery. Mr. Seaberg was Co-founder and first CEO of ACIST Medical, Inc., which was acquired by Bracco, Inc. for $100 million in 2001.
Alexander S. Yevzlin, MD, CEO, CMO, Co-Founder and Director
Alexander S. Yevzlin, MD, CEO, CMO, Co-Founder and Director
Alexander S. Yevzlin, MD, CEO, CMO, Co-Founder and Director
Dr. Yevzlin is currently a Professor of Medicine at University of Michigan and Director of Interventional Nephrology. After receiving his undergraduate degree magna cum laude from Dartmouth College he attended medical school at The Ohio State University, internship and residency training at the University of Michigan, and his Nephrology
Dr. Yevzlin is currently a Professor of Medicine at University of Michigan and Director of Interventional Nephrology. After receiving his undergraduate degree magna cum laude from Dartmouth College he attended medical school at The Ohio State University, internship and residency training at the University of Michigan, and his Nephrology fellowship at Northwestern University. Dr. Yevzlin has published or presented over 150 manuscripts, abstracts, and invited lectures. He is the founder of several start-up companies and has served in the roles of CMO, CSO, and board member in the vascular access space. He is the inventor of the Phraxis technology and a Co-Founder of the Company.
John Zentgraf, COO, Co-Founder and Director
Alexander S. Yevzlin, MD, CEO, CMO, Co-Founder and Director
John Zentgraf, COO, Co-Founder and Director
Currently, Mr. Zentgraf is the COO of NitriCap Medical Inc. developing a new antimicrobial technology for use with in-dwelling catheters. Mr. Zentgraf has 40+ years medical device industry experience including 21 years with Guidant where he led a team of 1,300 engineers and scientists through all phases of implantable product development
Currently, Mr. Zentgraf is the COO of NitriCap Medical Inc. developing a new antimicrobial technology for use with in-dwelling catheters. Mr. Zentgraf has 40+ years medical device industry experience including 21 years with Guidant where he led a team of 1,300 engineers and scientists through all phases of implantable product development, basic and applied research, and advanced technology development.
Mr. Zentgraf is an experienced entrepreneur, co-founding Phraxis Inc, Abilitech Medical, and Neochord Inc, and leading products through regulatory approval in the United States and Europe.
Mr. Zentgraf has extensive experience in analyzing emerging clinical technology, defining product requirements, executing design-control development, building FDA-compliant quality systems, and contract manufacturing design transfer process.